Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07330622Recruiting

Polish Registry of Percutaneous Coronary Intervention for Chronic Total Occlusions

Role: collaborator

NCT06507449Not ApplicableEnrolling By Invitation

The Influence of Modifying Highly Calcified Coronary Lesions on Coronary Microcirculation

Role: collaborator

NCT05118178Completed

Atherosclerosis in Chemotherapy-related Cardiotoxicity

Role: collaborator

NCT06697093Recruiting

Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock

Role: collaborator

NCT06136689Unknown

Role of Aortic Valve Composition in Pathophysiology and Diagnosis of Aortic Stenosis

Role: collaborator

NCT04879069Recruiting

Polish Multicenter PERTs PE Outcomes Registry

Role: collaborator

NCT01930773Phase 3Unknown

Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)

Role: collaborator

All 7 trials loaded